Future Perspectives and Challenges of Prostate MR Imaging.

about

Future Perspectives and Challenges of Prostate MR Imaging.

Item

http://www.wikidata.org/entity/Q50112903

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Future Perspectives and Challenges of Prostate MR Imaging.

@en

Future Perspectives and Challenges of Prostate MR Imaging.

@nl

type

Item

label

Future Perspectives and Challenges of Prostate MR Imaging.

@en

Future Perspectives and Challenges of Prostate MR Imaging.

@nl

prefLabel

Future Perspectives and Challenges of Prostate MR Imaging.

@en

Future Perspectives and Challenges of Prostate MR Imaging.

@nl

P1476

Future Perspectives and Challenges of Prostate MR Imaging.

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

P2860

Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research

Recent changes in prostate cancer screening practices and prostate cancer epidemiology.

The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.

Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Prostate-cancer mortality at 11 years of follow-up.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

P304

327-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RCL.2017.10.013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29420986

http://www.w3.org/2001/XMLSchema#string

P932

5808592

http://www.w3.org/2001/XMLSchema#string